We began to validate the FGF18 expression in paired normal and cancer tissues of 82 ccRCC patients enrolled between 2008 and 2014 in Huashan Hospital with tissue microarray (Table 1). Here, FGF18 is linked to nonpapillary renal cell carcinoma.